Page last updated: 2024-09-05

esketamine and Dissociation

esketamine has been researched along with Dissociation in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Chen, G; Drevets, WC; Fedgchin, M; Furey, ML; Hibar, D; Kolb, H; Popova, V; Saad, Z; Singh, JB	1
Brennan, E; Liebowitz, MR; Moran, M; Patel, A; Pereira, S; Wallier, J	1
Berk, M; Brietzke, E; Dodd, S; Gorwood, P; Ho, R; Iosifescu, DV; Kasper, S; Kratiuk, K; Lee, JG; Lee, Y; Lopez Jaramillo, C; Lui, LMW; Mansur, RB; McIntyre, RS; Murrough, JW; Nemeroff, CB; Papakostas, GI; Rosenblat, JD; Sanacora, G; Stahl, S; Subramaniapillai, M; Thase, M; Vieta, E; Young, AH; Zarate, CA	1

Reviews

1 review(s) available for esketamine and Dissociation

Article	Year
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5 Topics: Antidepressive Agents; Delivery of Health Care; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Excitatory Amino Acid Antagonists; Humans; Hypertension; Implementation Science; Ketamine; Lower Urinary Tract Symptoms; Monitoring, Physiologic; Patient Selection; Personnel Staffing and Scheduling; Psychoses, Substance-Induced; Substance-Related Disorders; Suicidal Ideation	2021

Article

Year

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.

The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5

Topics: Antidepressive Agents; Delivery of Health Care; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Excitatory Amino Acid Antagonists; Humans; Hypertension; Implementation Science; Ketamine; Lower Urinary Tract Symptoms; Monitoring, Physiologic; Patient Selection; Personnel Staffing and Scheduling; Psychoses, Substance-Induced; Substance-Related Disorders; Suicidal Ideation

2021

Trials

1 trial(s) available for esketamine and Dissociation

Article	Year
Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials. The international journal of neuropsychopharmacology, 2020, 12-03, Volume: 23, Issue:9 Topics: Adult; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketamine; Male; Middle Aged; Nasal Sprays; Outcome Assessment, Health Care; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Opioid, mu	2020

Article

Year

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.

The international journal of neuropsychopharmacology, 2020, 12-03, Volume: 23, Issue:9

Topics: Adult; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketamine; Male; Middle Aged; Nasal Sprays; Outcome Assessment, Health Care; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Opioid, mu

2020

Other Studies

1 other study(ies) available for esketamine and Dissociation

Article	Year
Managing dissociative symptoms following the use of esketamine nasal spray: a case report. International clinical psychopharmacology, 2021, Volume: 36, Issue:1 Topics: Administration, Intranasal; Depressive Disorder, Major; Dissociative Disorders; Female; Humans; Ketamine; Middle Aged; Nasal Sprays	2021